FDA approves generic drug for a rare genetic condition, but not for autism

Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for patients living with cerebral folate transport deficiency due to the

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
Health and Me on MSN

What science says about leucovorin - the drug White House touted for autism

The US FDA approved leucovorin for a rare genetic condition causing cerebral folate deficiency. Though studied as a potential autism therapy, evidence remains limited, even as some parents report improvements and researchers urge caution.

FDA finds little evidence that a drug touted by Trump can help people with autism

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.

The FDA approves leucovorin for rare genetic condition and not for autism

The U.S. Food and Drug Administration on Tuesday approved leucovorin, a synthetic form of vitamin B9, as a treatment for a rare genetic condition that causes folate deficiencies in the brain. The